Lejeune P, Gunselmann W, Hoppe I, Mummel P, Petersen B, Winkler E, Gfrerer G, Schreiber U
Clin Exp Hypertens A. 1985;7(11):1541-52. doi: 10.3109/10641968509073608.
114 patients from four clinics participated in a double blind study designed to assess the efficacy of a nifedipine-acebutolol fixed combination -10 mg + 100 mg - as compared with acebutolol -200 mg- in essential hypertension. During the ten week study the mean blood pressure readings (s.d.) 1-3 h after treatment decreased from 179.2/104.8 (10.2/6.2) to 150.3/87.7 (9.8/7.7) in the combination group and from 181.7/106.5 (14.4/7.0) to 150.4/89.0 (15.0/10.4) in the acebutolol group. The mean systolic and diastolic blood pressures were also decreased after exertion (load) and 24 hours after treatment at the end of the 6th week of the study. A doubling of the dose from week 7 to 10 did not change these figures. These results reveal the possibility of treating essential hypertension with a low dose of beta-adrenergic blocking agents in combination with 10 mg nifedipine. Both drugs were well tolerated. 3 patients (5%) in the combination group and 3 patients in the acebutolol group were withdrawn from the study because of headache and dizziness.
来自四家诊所的114名患者参与了一项双盲研究,该研究旨在评估硝苯地平-醋丁洛尔固定复方制剂(10毫克+100毫克)与醋丁洛尔(200毫克)治疗原发性高血压的疗效。在为期十周的研究中,联合用药组治疗后1至3小时的平均血压读数(标准差)从179.2/104.8(10.2/6.2)降至150.3/87.7(9.8/7.7),醋丁洛尔组从181.7/106.5(14.4/7.0)降至150.4/89.0(15.0/10.4)。在研究的第6周结束时,运动(负荷)后以及治疗后24小时,平均收缩压和舒张压也有所下降。从第7周至第10周将剂量加倍并未改变这些数值。这些结果表明,低剂量的β-肾上腺素能阻滞剂与10毫克硝苯地平联合使用治疗原发性高血压具有可行性。两种药物耐受性良好。联合用药组有3名患者(5%)因头痛和头晕退出研究,醋丁洛尔组也有3名患者退出研究。